Cargando…
Treating metastatic soft-tissue or bone sarcomas – potential role of ridaforolimus
Sarcomas of soft tissue and bone are a rare group of cancers hallmarked by relative insensitivity to cytotoxic chemotherapy. The development of targeted therapies in the treatment of sarcoma has been difficult due to the significant heterogeneity and rarity of these diseases. Inhibition of the mamma...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428242/ https://www.ncbi.nlm.nih.gov/pubmed/22942649 http://dx.doi.org/10.2147/OTT.S19055 |